These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32541515)

  • 1. DNA methylation-based diagnostic and prognostic biomarkers of nasopharyngeal carcinoma patients.
    Wu ZH; Zhou T; Sun HY
    Medicine (Baltimore); 2020 Jun; 99(24):e20682. PubMed ID: 32541515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation biomarkers for nasopharyngeal carcinoma.
    Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
    PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
    Gao P; Lu W; Hu S; Zhao K
    Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis.
    Zhang JZ; Wu ZH; Cheng Q
    Medicine (Baltimore); 2019 Nov; 98(48):e17997. PubMed ID: 31770211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring nasopharyngeal carcinoma genetics: Bioinformatics insights into pathways and gene associations.
    Che Ismail CL; Yusof NY; Mat Lazim N; Sarina S; Alwi ZB; Abdullah B
    Med J Malaysia; 2024 Sep; 79(5):615-625. PubMed ID: 39352166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
    World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis.
    Wang Y; Zhao Q; Lan N; Wang S
    Mol Med Rep; 2018 Apr; 17(4):4909-4916. PubMed ID: 29393436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
    Sang L; Wang XM; Xu DY; Zhao WJ
    World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
    Liu J; Li X; Yang S; Mou J; Lu H
    Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
    Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of key genes in nasopharyngeal carcinoma by bioinformatics analysis of high-throughput data.
    Ge Y; He Z; Xiang Y; Wang D; Yang Y; Qiu J; Zhou Y
    Mol Biol Rep; 2019 Jun; 46(3):2829-2840. PubMed ID: 30830589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis.
    Tai J; Park J; Han M; Kim TH
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of four key biomarkers and small molecule drugs in nasopharyngeal carcinoma by weighted gene co-expression network analysis.
    Pan X; Liu JH
    Bioengineered; 2021 Dec; 12(1):3647-3661. PubMed ID: 34261404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
    Li H; Liu JW; Liu S; Yuan Y; Sun LP
    Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray Analysis of Novel Genes Involved in Nasopharyngeal Carcinoma.
    Wang B; Wang W; Wang H; Liu W
    Bull Exp Biol Med; 2021 Mar; 170(5):658-664. PubMed ID: 33788105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Methylation Biomarkers for Nasopharyngeal Carcinoma: Diagnostic and Prognostic Tools.
    Jiang W; Cai R; Chen QQ
    Asian Pac J Cancer Prev; 2015; 16(18):8059-65. PubMed ID: 26745039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
    Mi JL; Xu M; Liu C; Wang RS
    Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated bioinformatics analysis of aberrantly-methylated differentially-expressed genes and pathways in age-related macular degeneration.
    Shen Y; Li M; Liu K; Xu X; Zhu S; Wang N; Guo W; Zhao Q; Lu P; Yu F; Xu X
    BMC Ophthalmol; 2020 Mar; 20(1):119. PubMed ID: 32209064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.